Genetically modified T cell therapy appears to be safe, lasting in decade-long study of HIV patients
Wednesday, May 2, 2012 - 14:30
in Health & Medicine
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers report. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.